Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 596 Lung Neoplasms 187 Neoplasms 66 Neoplasm Metastasis 46 Mesothelioma, Malignant 45 Adenocarcinoma of Lung 41 Mesothelioma 39 Colorectal Neoplasms 29 Carcinoma 23 Breast Neoplasms 23 Parkinson Disease 4, Autosomal Dominant Lewy Body 21 Meningeal Carcinomatosis 19 Head and Neck Neoplasms 19 Brain Neoplasms 18 Ovarian Neoplasms 17 Adenocarcinoma 15 Small Cell Lung Carcinoma 14 NSCLC 14 Pancreatic Neoplasms 12 Melanoma 12 Squamous Cell Carcinoma of Head and Neck 11 Recurrence 11 Lung Diseases 10 Carcinoma, Transitional Cell 10 Uterine Cervical Neoplasms 9 Neoplasms by Site 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Thoracic Neoplasms 8 Non-squamous Non-small Cell Lung Cancer 8 Carcinoma, Bronchogenic 8

Interventions

ispinesib 2 trifluridine tipiracil drug combination 1 trametinib 1 tipiracil 1 irinotecan sucrosofate 1 Vincristine 1 Trifluridine 1 Temozolomide 1 TP protocol 1 SB 743921 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Exercise Therapy 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor Cancer × Pemetrexed × Clear all

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡